Allopurinol Desensitization: Is There Still a Place in Clinical Practice? [PDF]
Louthrenoo W.
europepmc +1 more source
Rapid Clinical Improvement Temporally Associated with Off-Label LetiFend<sup>®</sup> Vaccination in Canine Leishmaniasis: A Case Report. [PDF]
Werner T, Rămneanţu M, Naucke TJ.
europepmc +1 more source
Allopurinol-Induced Leukocytoclastic Vasculitis With Systemic Inflammatory Response: A Case Report From Azerbaijan. [PDF]
Ravikumar D, Silven G, Salimzade H.
europepmc +1 more source
Experience with early treatment using febuxostat in a patient with adenine phosphoribosyltransferase deficiency after pediatric kidney transplantation: a case report. [PDF]
Aoki Y +13 more
europepmc +1 more source
Screening and Mechanistic Investigation of Synergistic Xanthine Oxidase Inhibitors Based on Structure-Activity Relationships. [PDF]
Qu Z, Zhang X, Cui Y, Yu M, Li L.
europepmc +1 more source
Allopurinol-Induced Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Case Report and Review of the Published Evidence From India. [PDF]
Shinde A +4 more
europepmc +1 more source
Differential associations of febuxostat and allopurinol with incident and worsening frailty risk in nephrology patients. [PDF]
Lee SY +5 more
europepmc +1 more source
Variations in the Management of Uncontrolled Gout Between Rheumatologists and Nephrologists: A Retrospective Medical Record Review. [PDF]
Saag K +7 more
europepmc +1 more source
Modulation of Spinal Mu-Opioid Receptor Expression by Selective Adenosine A1 and A3 Receptor Agonists and Allopurinol in a Rat Model of Neuropathic Pain. [PDF]
Kim J, Kim NH, Joo JD, Kwon SY.
europepmc +1 more source
Cardiovascular Safety of Febuxostat vs. Allopurinol in Gout Patients with Cardiovascular Diseases: A Target Trial Emulation. [PDF]
Wang X +5 more
europepmc +1 more source

